MAP2K7 and breast cancer: Furthermore, the IGF‐1 receptor (IGF‐1R) can activate the Ras/Raf/MEK/ERK signaling pathway, enhancing the expression of cyclin D1 and accelerating the G1/S phase transition, thus promoting the proliferative capacity of breast cancer cells [18].